Recombinant human decorin inhibits TGF-beta1-induced contraction of collagen lattice by hypertrophic scar fibroblasts.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Burns

• Publication date

  2009-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.burns.2008.08.021PMID 19167828
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of decorin on the expression of alpha-smooth muscle actin in a human myofibroblast cell line.

  2008cited by this paper
• Recombinant human decorin inhibits cell proliferation and downregulates TGF-beta1 production in hypertrophic scar fibroblasts.

  2007cited by this paper
• Effects of decorin on the expression of α-smooth muscle actin in a human myofibroblast cell line

  2007cited by this paper
• Conditioned medium from keloid keratinocyte/keloid fibroblast coculture induces contraction of fibroblast‐populated collagen lattices

  2005cited by this paper
• Abrogation of Transforming Growth Factor-β Signaling by SMAD7 Inhibits Collagen Gel Contraction of Human Dermal Fibroblasts*

  2005influential reference
• Myofibroblasts in Palatal Wound Healing: Prospects for the Reduction of Wound Contraction after Cleft Palate Repair

  2005cited by this paper
• Collagen crosslinking and cell density have distinct effects on fibroblast‐mediated contraction of collagen gels

  2003cited by this paper
• Fibroblast biology in three-dimensional collagen matrices.

  2003cited by this paper
• Fibrinogen inhibits fibroblast‐mediated contraction of collagen

  2003cited by this paper
• Transforming growth factor beta stimulates fibroblast-collagen matrix contraction by different mechanisms in mechanically loaded and unloaded matrices.

  2002cited by this paper
• Myofibroblasts and mechano-regulation of connective tissue remodelling

  2002cited by this paper
• Scar Contractures, Hypertrophic Scars, and Keloids

  2001cited by this paper
• Mechanical tension controls granulation tissue contractile activity and myofibroblast differentiation.

  2001cited by this paper
• TGF-beta1-induced PAI-1 gene expression requires MEK activity and cell-to-substrate adhesion.

  2001cited by this paper
• Effects of collagen matrix containing transforming growth factor (TGF)-beta(1) on wound contraction.

  2001cited by this paper
• Alpha-smooth muscle actin expression upregulates fibroblast contractile activity.

  2001cited by this paper
• The Use of an Antifibrosis Agent to Improve Muscle Recovery after Laceration *

  2001cited by this paper
• Fibroblast contraction of a collagen-GAG matrix.

  2001cited by this paper
• Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung.

  2001cited by this paper
• Hypertrophic scar tissues and fibroblasts produce more transforming growth factor‐β1 mRNA and protein than normal skin and cells

  2000cited by this paper
• PAI‐1 gene expression is regionally induced in wounded epithelial cell monolayers and required for injury repair

  2000cited by this paper
• Control of wound contraction. Basic and clinical features.

  2000cited by this paper
• On the nature of hypertrophic scars and keloids: a review.

  1999cited by this paper
• Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy.

  1997cited by this paper
• Wound Healing--Aiming for Perfect Skin Regeneration

  1997cited by this paper
• Modulation of collagen gel contraction by decorin.

  1996cited by this paper
• Model Structure of Decorin and Implications for Collagen Fibrillogenesis*

  1996cited by this paper
• Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney

  1996cited by this paper
• Neutralising antibody to TGF-beta 1,2 reduces cutaneous scarring in adult rodents.

  1994cited by this paper
• Fibroblasts, myofibroblasts, and wound contraction

  1994cited by this paper
• Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts

  1993cited by this paper
• Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease

  1992cited by this paper
• Negative regulation of transforming growth factor-β by the proteoglycan decorin

  1990cited by this paper
• Wound contraction following transplantation of microskin autografts with overlaid skin allograft in experimental animals.

  1990cited by this paper
• Fibroblasts from wounds of different stages of repair vary in their ability to contract a collagen gel in response to growth factors

  1990cited by this paper
• Temporal relationships of F-actin bundle formation, collagen and fibronectin matrix assembly, and fibronectin receptor expression to wound contraction

  1990cited by this paper
• Negative regulation of transforming growth factor-beta by the proteoglycan decorin.

  1990cited by this paper
• Characterization of the dermatan sulfate proteoglycans, DS-PGI and DS-PGII, from bovine articular cartilage and skin isolated by octyl-sepharose chromatography.

  1989cited by this paper
• Transforming growth factor beta stimulates collagen-matrix contraction by fibroblasts: implications for wound healing.

  1988cited by this paper
• Studies on vascular smooth muscle cells and dermal fibroblasts in collagen matrices. Effects of heparin.

  1986cited by this paper
• Isolation of dermatan sulfate proteoglycans from mature bovine articular cartilages.

  1985cited by this paper
• Cultured Myofibroblasts: A Useful Model to Study Wound Contraction and Pathological Contracture

  1985cited by this paper
• Proteoglycans of developing bone.

  1983cited by this paper
• Fibroblast traction as a mechanism for collagen morphogenesis

  1981cited by this paper
• Wound management and infection.

  1979cited by this paper
• Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro.

  1979cited by this paper
• The effect of skin graft preparation on wound contraction.

  1976cited by this paper
• GRANULATION TISSUE AS A CONTRACTILE ORGAN

  1972cited by this paper

• Controlled decorin delivery from injectable microgels promotes scarless vocal fold repair

  2025cites this paper
• Potential implications of granzyme B in keloids and hypertrophic scars through extracellular matrix remodeling and latent TGF-β activation

  2025cites this paper
• Effect of Decorin and Aligned Collagen Fibril Topography on TGF-β1 Activation of Corneal Keratocytes

  2025cites this paper
• Decorin the anti-fibrotic proteoglycan and its progression in therapy.

  2025cites this paper
• Tree thorns-inspired hyaluronic acid-based dissolving microneedles loaded with salvianolic acid B for effective hypertrophic scar treatment with enhanced long-term stability.

  2025cites this paper
• An Update on Molecular Mechanisms of Scarring—A Narrative Review

  2024cites this paper
• The effects of TGF‐β1 and IFN‐α2b on decorin, decorin isoforms and type I collagen in hypertrophic scar dermal fibroblasts

  2024cites this paper
• Perifascial areolar tissue graft promotes angiogenesis and wound healing in an exposed ischemic component rabbit model

  2024cites this paper
• Global proteomic analysis reveals lysine succinylation is involved in the pathogenesis of hypertrophic scar.

  2024cites this paper
• Hypertrophic Scar.

  2023cites this paper
• Engineered multi-functional, pro-angiogenic collagen-based scaffolds loaded with endothelial cells promote large deep burn wound healing

  2023cites this paper
• Local delivery of decorin via hyaluronic acid microrods improves cardiac performance and ventricular remodeling after myocardial infarction

  2023cites this paper
• Local decorin delivery via hyaluronic acid microrods improves cardiac performance, ventricular remodeling after myocardial infarction

  2023cites this paper
• Wound Healing, Scarring and Management.

  2023cites this paper
• Identifying Biomarkers for Osteogenic Potency Assay Development.

  2023cites this paper
• Effect of Mortalin on Scar Formation in Human Dermal Fibroblasts and a Rat Incisional Scar Model

  2022cites this paper
• Matrix Metalloproteinases and Their Inhibitors in Pulmonary Fibrosis: EMMPRIN/CD147 Comes into Play

  2022cites this paper
• TRANSDERMAL THERAPEUTIC SYSTEMS–AN INNOVATIVE METHOD TO PREVENT THE FORMATION OF KELOIDS

  2022cites this paper
• The matricellular protein decorin delivered intradermally with coacervate improves wound resolution in the CXCR3‐deficient mouse model of hypertrophic scarring

  2022cites this paper
• The effect of TGFβRI inhibition on fibroblast heterogeneity in hypertrophic scar 2D in vitro models.

  2021cites this paper
• Stimulation of toll‐like receptor pathways by burn eschar tissue as a possible mechanism for hypertrophic scarring

  2021cites this paper
• Distal Lung Microenvironment Triggers Release of Mediators Recognized as Potential Systemic Biomarkers for Idiopathic Pulmonary Fibrosis

  2021cites this paper
• Made in Germany: A Quality Indicator Not Only in the Automobile Industry But Also When It Comes to Skin Replacement: How an Automobile Textile Research Institute Developed a New Skin Substitute

  2021cites this paper
• The Biology of Extracellular Matrix Proteins in Hypertrophic Scarring

  2021cites this paper
• Small Leucine-Rich Proteoglycans in Skin Wound Healing

  2020cites this paper
• Distinct effects of different matrix proteoglycans on collagen fibrillogenesis and cell-mediated collagen reorganization

  2020cites this paper
• Obesity reduces mammary epithelial cell TGFβ1 activity through macrophage‐mediated extracellular matrix remodeling

  2020cites this paper
• Multifaceted transforming growth factor-beta (TGFβ) signalling in glioblastoma.

  2020cites this paper
• New insights into the pathogenesis of Peyronie’s disease: A narrative review

  2020cites this paper
• Biological approaches for hypertrophic scars

  2019cites this paper
• Current and upcoming therapies to modulate skin scarring and fibrosis.

  2019cites this paper
• Keloids – an extensive review in the light of recent literature

  2019cites this paper
• Strategy for hypertrophic scar therapy: Improved delivery of triamcinolone acetonide using mechanically robust tip-concentrated dissolving microneedle array.

  2019cites this paper
• LY2109761 reduces TGF-β1-induced collagen production and contraction in hypertrophic scar fibroblasts

  2018cites this paper
• Abnormal scar identification with spherical-nucleic-acid technology

  2018cites this paper
• Recent Understandings of Biology, Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids

  2018cites this paper
• The effects of platelet‐rich plasma on hypertrophic scars fibroblasts

  2018cites this paper
• 45 – Molecular and Cellular Basis of Hypertrophic Scarring

  2018cites this paper
• Anti-Scarring Drug Screening with Near-Infrared Molecular Probes Targeting Fibroblast Activation Protein-α.

  2018cites this paper
• The effects of platelet-rich plasma on hypertrophic scars fibroblasts

  2018cites this paper
• Decorin-containing collagen hydrogels as dimensionally stable scaffolds to study the effects of compressive mechanical loading on angiogenesis

  2017cites this paper
• Biological Principles of Scar and Contracture.

  2017cites this paper
• Current Therapeutic Approach to Hypertrophic Scars

  2017cites this paper
• Development of human skin equivalents mimicking skin aging : contrast between papillary and reticular fibroblasts as a lead

  2017cites this paper
• Growth of early or midterm human foetal skin in a burn model: establishment of the model, morphological and histological observations

  2017cites this paper
• Differential effect of extracellular matrix derived from papillary and reticular fibroblasts on epidermal development in vitro

  2017cites this paper
• Molecular and Cellular Biology of Wound Healing and Skin Regeneration

  2016cites this paper
• PLGA based drug delivery systems: Promising carriers for wound healing activity

  2016cites this paper
• Transforming growth factor beta (TGF‐β) isoforms in wound healing and fibrosis

  2016cites this paper
• Deficiency Alters Transforming Growth Factor-β Expression during Mouse Wound Healing

  2016cites this paper
• Vocal fold myofibroblast profile of scarring

  2016cites this paper
• Effect of Adenovirus-mediated Decorin Gene Therapy on Fibrotic Remodeling in Tissue-engineered Skin

  2016cites this paper
• ILK–PI3K/AKT pathway participates in cutaneous wound contraction by regulating fibroblast migration and differentiation to myofibroblast

  2016cites this paper
• Fibromodulin Deficiency Alters Transforming Growth Factor-beta Expression during Mouse Wound Healing

  2016cites this paper
• The evidence for natural therapeutics as potential anti-scarring agents in burn-related scarring

  2016cites this paper
• A novel dermal matrix generated from burned skin as a promising substitute for deep-degree burns therapy

  2016cites this paper
• Effect of P144® (Anti-TGF-β) in an “In Vivo” Human Hypertrophic Scar Model in Nude Mice

  2015cites this paper
• MicroRNA 181b Regulates Decorin Production by Dermal Fibroblasts and May Be a Potential Therapy for Hypertrophic Scar

  2015cites this paper
• Shikonin reduces TGF-β1-induced collagen production and contraction in hypertrophic scar-derived human skin fibroblasts

  2015cites this paper
• Dermal Fibroblasts from the Red Duroc Pig Have an Inherently Fibrogenic Phenotype: An In Vitro Model of Fibroproliferative Scarring

  2015cites this paper
• Differences in Hypertrophic Scar Fibroblasts according to Scar Severity: Expression of Transforming Growth Factor β1 at the mRNA and Protein Levels

  2015cites this paper
• Inhibitory effect of TGF-β peptide antagonist on the fibrotic phenotype of human hypertrophic scar fibroblasts

  2015cites this paper
• Fibromodulin-Deficiency Alters Temporospatial Expression Patterns of Transforming Growth Factor-β Ligands and Receptors during Adult Mouse Skin Wound Healing

  2014cites this paper
• siRNA-targeting transforming growth factor-β type I receptor reduces wound scarring and extracellular matrix deposition of scar tissue.

  2014cites this paper
• New molecular medicine-based scar management strategies.

  2014cites this paper
• Learning from Tissue Equivalents: Biomechanics and Mechanobiology

  2014cites this paper
• СОВРЕМЕННЫЕ ПОДХОДЫ ФАРМАКОЛОГИЧЕСКОЙ КОРРЕКЦИИ ПАТОЛОГИЧЕСКИХ РУБЦОВ

  2014cites this paper
• Integral Role of Platelet-Derived Growth Factor in Mediating Transforming Growth Factor-β1–Dependent Mesenchymal Stem Cell Stiffening

  2014cites this paper
• Overexpression of miR‐200b inhibits the cell proliferation and promotes apoptosis of human hypertrophic scar fibroblasts in vitro

  2014cites this paper
• TGF-β1 induces differentiation of papillary fibroblasts to reticular fibroblasts in monolayer culture but not in human skin equivalents

  2014cites this paper
• The contribution of melanocytes to pathological scar formation during wound healing.

  2013cites this paper
• Granzyme B in skin aging, injury and repair

  2013cites this paper
• Medical Hypothesis The contribution of melanocytes to pathological scar formation during wound healing

  2013cites this paper
• The role of the TGF-β family in wound healing, burns and scarring: a review.

  2012cites this paper
• Organ fibrosis inhibited by blocking transforming growth factor-β signaling via peroxisome proliferator-activated receptor γ agonists.

  2012cites this paper
• Decreased plasma decorin levels following acute ischemic stroke: correlation with MMP-2 and differential expression in TOAST subtypes.

  2012cites this paper
• A Review of Fetal Scarless Healing

  2012cites this paper
• The role of osteopontin and osteopontin aptamer (OPN-R3) in fibroblast activity.

  2012cites this paper
• The extracellular matrix regulates myoblast migration during wound healing.

  2012cites this paper
• Granzyme B in injury, inflammation, and repair.

  2012cites this paper
• The evidence for the role of transforming growth factor‐beta in the formation of abnormal scarring

  2011cites this paper
• Keratinocytes stimulate fibroblast hyaluronan synthesis through the release of stratifin: A possible role in the suppression of scar tissue formation

  2011cites this paper
• Prevention of peritoneal adhesions: a promising role for gene therapy.

  2011cites this paper
• Hypertrophic Scarring and Keloids: Pathomechanisms and Current and Emerging Treatment Strategies

  2011cites this paper
• Deficiency of Biglycan Causes Cardiac Fibroblasts to Differentiate into a Myofibroblast Phenotype*

  2011cites this paper
• TGF-beta, IL-6, IL-17 and CTGF direct multiple pathologies of chronic cardiac allograft rejection.

  2010cites this paper
• Cell motility and mechanics in three-dimensional collagen matrices.

  2010cites this paper
• Fibroblasts as matrix modulating cells in asthma and COPD

  2009cites this paper
• Modulation of extracellular matrix through keratinocyte- fibroblast crosstalk

  2009cites this paper